DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for ChemoCentryx, Inc. (CCXI)
« Back to company indexCCXI Chatter Timeline
Stock Ticker for CCXI
Most Active Tweeters for CCXI
| User | Tweets |
|---|---|
| @Tickeron | 12 |
| @ThisLincolnian | 4 |
| @nociFTW | 4 |
| @1MinuteStock | 4 |
| @BlueBioNow | 3 |
Recent Tweets for CCXI
 |
@BioPharmInsight Can $CCXI’s avacopan for #ANCA associated vasculitis achieve first-line status? Senior Reporter @manasivaidya22 ask… https://t.co/nLJDsQO105 October 21st 2019, 10:10am |
 |
@BlueBioNow $CCXI This one is getting bipolar : ) -3.13 % change recently https://t.co/MERF23zxao October 21st 2019, 8:10am |
 |
@Tickeron $CCXI's Aroon indicator drops into Downtrend on September 20, 2019. View odds for this and other indicators:… https://t.co/kbr8Ee7g8m October 20th 2019, 11:10pm |
 |
@AmericanBanking ChemoCentryx Inc $CCXI Given Average Rating of “Buy” by Analysts https://t.co/qNyjrBAzFp #stocks October 20th 2019, 7:10am |
 |
@macondailynews ChemoCentryx Inc $CCXI Given Average Rating of “Buy” by Analysts https://t.co/BVrZ9jVEWW October 20th 2019, 7:10am |
 |
@TheMarketsDaily ChemoCentryx Inc $CCXI Given Average Rating of “Buy” by Brokerages https://t.co/6tTqWbQecb October 20th 2019, 7:10am |
|
@Tickeron $CCXI's Aroon indicator drops into Downtrend on September 20, 2019. View odds for this and other indicators:… https://t.co/ZJlgA7TWWs October 20th 2019, 2:10am |
 |
@1MinuteStock Not sure what to do with $CCXI? Explore our #fundamental pros and cons. https://t.co/IQcH8uO7cY October 20th 2019, 12:10am |
 |
@gcassidy718 $CCXI Hoping to exit this position at some point . . . -3.13 % change recently https://t.co/euTK18qFmi October 19th 2019, 11:10pm |
|
@1MinuteStock Do you know that #WallStreet price for $CCXI is $19 https://t.co/2THU4aNUGJ October 19th 2019, 11:10pm |
|
@1MinuteStock We calculated 63-day Expected Return of $CCXI for you: -3.83% https://t.co/UWhwbtw53i October 19th 2019, 9:10pm |
|
@1MinuteStock Unicorn Bay rating for $CCXI is 2.69 out of 5. https://t.co/FPwmM5CDA1 October 19th 2019, 8:10pm |
 |
@dailypoliticaln JPMorgan Chase & Co. Reaffirms Buy Rating for ChemoCentryx $CCXI https://t.co/6wr4lmZUQ4 October 19th 2019, 7:10am |
 |
@TickerReport JPMorgan Chase & Co. Reaffirms Buy Rating for ChemoCentryx $CCXI https://t.co/apHnbuaY79 October 19th 2019, 7:10am |
|
@Tickeron $CCXI in Uptrend: Stochastic indicator stays in overbought zone for 8 days. View odds for this and other indicators… https://t.co/T8IIlsvXYW October 19th 2019, 5:10am |
 |
@biotechw2019 $CCXI cloud break out ! https://t.co/xTF3FjTIWL October 18th 2019, 10:10am |
 |
@dakotafinancial ChemoCentryx $CCXI Raised to “Buy” at BidaskClub https://t.co/aaoQ3GjNz3 October 18th 2019, 1:10am |
|
@Tickeron $CCXI's Aroon indicator drops into Downtrend on September 20, 2019. View odds for this and other indicators:… https://t.co/61B4HcMIQ0 October 18th 2019, 1:10am |
 |
@TranscriptDaily JPMorgan Chase & Co. Reiterates Buy Rating for ChemoCentryx $CCXI https://t.co/iP3dkWevCm October 17th 2019, 4:10pm |
 |
@registrarjourn ChemoCentryx $CCXI Rating Reiterated by JPMorgan Chase & Co. https://t.co/2zV6EHpqjH October 17th 2019, 4:10pm |
 |
@EnterpriseLeade ChemoCentryx $CCXI Rating Reiterated by JPMorgan Chase & Co. https://t.co/j2YKZDlJfz October 17th 2019, 4:10pm |
 |
@ZolmaxNews ChemoCentryx $CCXI Given “Buy” Rating at JPMorgan Chase & Co. https://t.co/UnTeS3vmZV October 17th 2019, 4:10pm |
|
@AmericanBanking ChemoCentryx $CCXI Earns Buy Rating from JPMorgan Chase & Co. https://t.co/ag6y77BkxW #stocks October 17th 2019, 3:10pm |
 |
@StockflareUS $CCXI: The recommendation for ChemoCentryx Inc has been upgraded to Strong Buy. (https://t.co/3ffNaGNTcQ) October 17th 2019, 9:10am |
 |
@bbnsnews BidaskClub Upgrades ChemoCentryx $CCXI to “Buy” https://t.co/LhNGnxhiil October 17th 2019, 1:10am |
|
@Tickeron $CCXI in Uptrend: Stochastic indicator is staying in overbought zone for 6 days. View odds for this and other indic… https://t.co/7l2nIDOncV October 17th 2019, 1:10am |
 |
@bret_jensen $CCXI The Biotech Analyst Run Down For Tuesday https://t.co/fCTon5tWW9 October 16th 2019, 8:10am |
 |
@ThisLincolnian BidaskClub Upgrades ChemoCentryx $CCXI to Buy https://t.co/q11PF87pch October 16th 2019, 3:10am |
 |
@WeekHerald BidaskClub Upgrades ChemoCentryx $CCXI to Buy https://t.co/a3EGCU1I8N October 16th 2019, 3:10am |
|
@Tickeron $CCXI's Aroon indicator drops into Downtrend on September 20, 2019. View odds for this and other indicators:… https://t.co/9V4abtvzpS October 16th 2019, 12:10am |
|
@ZolmaxNews Short Interest in ChemoCentryx Inc $CCXI Drops By 15.4% https://t.co/gcIaYYyaXk October 15th 2019, 8:10pm |
|
@dailypoliticaln Short Interest in ChemoCentryx Inc $CCXI Drops By 15.4% https://t.co/QaPJKtC5MC October 15th 2019, 8:10pm |
|
@biotechw2019 $CCXI cloud break out is poised ! https://t.co/PZQmxFYEhR October 15th 2019, 5:10pm |
 |
@happyycamperr @biotechinvstr Whats your take on $CCXI following your epic call on $IFRX? Seems like a much different type of ris… https://t.co/mLeAi6ZbcB October 15th 2019, 2:10pm |
 |
@semodough $CCXI positive ADVOCATE results, we see potential for ~90-110%+ upside in CCXI shares versus downside of ~45-80%+ o… https://t.co/IOtBdkroTI October 15th 2019, 12:10pm |
|
@semodough JP $CCXI hosted ChemoCentryx team for a West Coast investor group lunch, where the focus of the discussion (no surp… https://t.co/QZxkgmg8Q7 October 15th 2019, 12:10pm |
|
@BlueBioNow $CCXI That's rough. . . -2.44 % change recently https://t.co/MERF23zxao October 15th 2019, 11:10am |
 |
@buckjoe RT @nociFTW: $CCXI awarded rare disease grant by the FDA, related to avacopan in C3 glomerulopathy. Well done! October 15th 2019, 11:10am |
|
@Tickeron $CCXI's Aroon indicator drops into Downtrend on September 20, 2019. View odds for this and other indicators:… https://t.co/cG5cEzRFko October 15th 2019, 12:10am |
|
@fairfieldcurren ChemoCentryx $CCXI Upgraded at ValuEngine https://t.co/01mlAyc9ha #markets October 14th 2019, 6:10pm |
 |
@ledgerzette ChemoCentryx $CCXI Upgraded at ValuEngine https://t.co/OfBJhncaMk #stocks October 14th 2019, 6:10pm |
 |
@intercooleronli ChemoCentryx $CCXI Upgraded at ValuEngine https://t.co/pNRspLqdZ9 #investingnews October 14th 2019, 6:10pm |
|
@TranscriptDaily ChemoCentryx $CCXI Upgraded at ValuEngine https://t.co/8IqwKltTEs October 14th 2019, 6:10pm |
 |
@WatchlistN ChemoCentryx $CCXI Lifted to “Strong-Buy” at ValuEngine https://t.co/sHEQp1nEbq October 14th 2019, 2:10pm |
|
@TickerReport ChemoCentryx $CCXI Lifted to “Strong-Buy” at ValuEngine https://t.co/2TtF2U4BlE October 14th 2019, 2:10pm |
 |
@nociFTW @biotechinvstr $ccxi long is a good bet at this price October 14th 2019, 1:10pm |
|
@Tickeron $CCXI's Aroon indicator drops into Downtrend on September 20, 2019. View odds for this and other indicators:… https://t.co/No8G23Hyyx October 13th 2019, 5:10am |
|
@WeekHerald BidaskClub Upgrades ChemoCentryx $CCXI to “Hold” https://t.co/sf5fFadGaf October 12th 2019, 7:10pm |
|
@bbnsnews ChemoCentryx $CCXI Cut to “Sell” at Zacks Investment Research https://t.co/aTaAraF6gf October 12th 2019, 7:10pm |
|
@TheMarketsDaily ChemoCentryx $CCXI Rating Increased to Strong-Buy at ValuEngine https://t.co/vmvmMgXBIQ October 12th 2019, 4:10pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.